Recent

% | $
Quotes you view appear here for quick access.

Galectin Therapeutics, Inc. Message Board

  • dr.vinmantoo dr.vinmantoo Jun 21, 2012 4:48 PM Flag

    How about that ONXX!!

    Remember that the lying ignorant pumper novelshe was saying ONXX was a POS when it was in the low $30s and upper $20s. I laughed at him bought more.


    Well, ONXX surged by more than 40% today or ~$20/share to close at almost $64/share. Obviously as an ONXX long I am pleased by the big stock price surge today.


    Remember when Az was calling ONXX a POS and was spouting off that Bayer would crush ONXX when ONXX sued Bayer over Regorafenib. I laughed at AZ and brought more ONXX. Well, ONXX won the lawsuit by forcing Bayer to settle and give ONXX of the Regorafenib world-wide. Regorafenib will be approved in GIST and possibly even in 4th line metastatic colon cancer for starters.

    I never understood what Bayer was thinking after they were forced to settled with ONXX and give them 20% of the Regorafenib revenues. I figured that settlement would make them buy ONXX since they probably could have bought ONXX for $50/share. If they are still interested, the buyout price has gone way, way up. I don't think that $100/share is out of the question now.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALT
1.62-0.15(-8.47%)Aug 26 3:59 PMEDT